Pelliccia, S.; Banchi, M.; De Marchi, L.; Cencini, E.; Seimonte, C.; Fabbri, A.; Nunzi, A.; Destefano, S.; Bocci, G.; Cox, M.C.
Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective Analysis. Cancers 2026, 18, 347.
https://doi.org/10.3390/cancers18020347
AMA Style
Pelliccia S, Banchi M, De Marchi L, Cencini E, Seimonte C, Fabbri A, Nunzi A, Destefano S, Bocci G, Cox MC.
Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective Analysis. Cancers. 2026; 18(2):347.
https://doi.org/10.3390/cancers18020347
Chicago/Turabian Style
Pelliccia, Sabrina, Marta Banchi, Lucrezia De Marchi, Emanuele Cencini, Claudia Seimonte, Alberto Fabbri, Andrea Nunzi, Susanna Destefano, Guido Bocci, and Maria Christina Cox.
2026. "Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective Analysis" Cancers 18, no. 2: 347.
https://doi.org/10.3390/cancers18020347
APA Style
Pelliccia, S., Banchi, M., De Marchi, L., Cencini, E., Seimonte, C., Fabbri, A., Nunzi, A., Destefano, S., Bocci, G., & Cox, M. C.
(2026). Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective Analysis. Cancers, 18(2), 347.
https://doi.org/10.3390/cancers18020347
